The 8th Oxylane Innovation Awards will take place on 18 December, 2013. This is a major event for Oxylane and its Decathlon stores, which place continuous innovation at the heart of their business model.
This year, ten innovations from nine brands will be competing for the awards. These are ingenious technical products suitable for all sports players, from beginners to advanced. These products can be seen as of now, as well as on the awards evening, at the event’s dedicated website: http://oia.oxylane.com.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/63480-oxylane-innovation-awards-at-decathlon
Executive Education at LUISS Business School is an experience aimed at inspiring people to develop hard and soft skills, innovative mind-set, entrepreneurship attitude and multi-ethnic interactions. “It is no longer about offering learning to enhance someone’s long term career – says Professor Paolo Boccardelli, the Dean – it is about creating direct impact in support of change. We intend to boost our student professional and personal growth while promoting corporate sustainability and social responsibility”.
LUISS Business School is the School of Business and Management of University LUISS Guido Carli, in Rome (Italy), which leads the development and the growth of individuals and companies. Through the Competence Centres & Labs, which are centres of Business Practice and Research, the School is full embedded in the innovation of the training programmes even thanks to the cooperation with Key Corporate Partners and an International Facultyin order to offer a real change to those who live the experience at LUISS BS.
Its reputation is based on strong values: openness in all the main issues; responsibility, because of its strong commitment with ethically and socially responsible issues; independence, in order to keep safe a very challenging environment.
To view the multimedia release please
http://www.multivu.com/players/English/7588251-luiss-bs-executive-education-italy/
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today recognizes that more than one million people in the United States with drug-resistant epilepsy continue to be treated unsuccessfully with drugs, despite the proven effectiveness of non-drug treatment options. LivaNova’s VNS Therapy®, for example, is a medical device treatment specifically designed for people with drug-resistant epilepsy that is already used by more than 85,000 people around the world.
One in three people with epilepsy has the type that is not well controlled with drugs, called drug-resistant epilepsy. For those people, prescribing more medicine is usually not the most effective option. In fact, research shows that if you haven’t found seizure freedom after your first two drugs, there is a 95 percent chance that no drug or combination of drugs will result in seizure freedom.
“Despite what we know about drug-resistant epilepsy, the majority of people affected by this condition will continue to be prescribed additional medications instead of being evaluated for surgery or seen in a specialized epilepsy facility,” said Jason Richey, president of LivaNova’s U.S. Region and general manager of the Neuromodulation Business Franchise. “This treatment gap means over one million individuals in the U.S. with undertreated epilepsy remain at risk for dangerous side effects of continued seizures, including injury, depression, memory issues and death.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7966451-livanova-vns-therapy-epilepsy/
GB Sciences, Inc. (OTCQB: GBLX) announces the success of its first annual, “Innovation in Medical Cannabis Therapies” (IMCT) Symposium, held on Friday, November 9th at the “Keep Memory Alive” Event Center at the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, Nevada. Throughout the day’s program, there was an emerging sense of heightened responsibility on the part of the cannabis industry to better address medical cannabis patients' needs through research and development of medical cannabis products that are better standardized, more easily-dosed, and made more widely-available to cannabis patients at a fair price.
To view the multimedia release go to:
https://www.multivu.com/players/English/8308958-gb-sciences-2018-medical-cannabis-therapies-symposium/
For a group of budding business people, living with senior citizens for five days gives impetus to their dreams. It also encourages innovation that could improve the lives of the aging. They are all participants in Brookdale’s Entrepreneur in Residence program, part of the company’s “Rewiring Aging” initiative to enrich seniors’ lives through technology. Recently launched by America’s largest senior living provider, the program offers those entrepreneurs developing products and services for seniors the opportunity to move in for that period of time so they can better understand the true wants and needs of the aging.
“The majority of start-ups focus on younger markets, but we have seen a growing number of entrepreneurs interested in building solutions for seniors and their families” said Andrew Smith, Brookdale’s director of strategy and innovation. “The 80 and above age group is America’s fastest-growing population. We believe there’s an enormous opportunity to enhance seniors’ lives with new technologies, services, products and business models. This program gives entrepreneurs a once-in-a-lifetime opportunity that we hope will inspire even more innovation for the aging.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7722155-brookdale-senior-living-innovate/
The sixth annual Productive Innovation Index released by IDEA Pharma today, which ranks biopharmaceutical companies by their ability to successfully bring innovations to market, sees Johnson & Johnson top the industry for the fourth year running.
The Productive Innovation Index measures, scores and celebrates a company’s ability to deliver innovation to patients, by objectively evaluating performance data based on a rolling five year period (2010-2015), and operates on the premise: if you gave the same molecule to two different companies in early phase, which would make the best of it?
The success of the Janssen Pharmaceutical Companies of Johnson & Johnson and its consolidation of 1st place across the past four years’ rankings is driven largely by innovations in the field of oncology, immunology, neuroscience and cardiovascular/metabolism. Notable performers include Zytiga® (prostate cancer), Imbruvica® (chronic lymphocytic leukemia and mantle cell lymphoma (co-developed and co-marketed with Pharmacyclics, an AbbVie company)), Simponi®/Simponi Aria® (rheumatoid arthritis), Stelara® (psoriasis and psoriatic arthritis), Invega Sustenna® and Invega Trinza® (schizophrenia).
To view the multimedia release go to:
http://www.multivu.com/players/uk/7770851-johnson-and-johnson-tops-idea-pharma/
Professor Lionel Tarassenko, CBE, Head of Engineering at the University of Oxford and Fellow of the Royal Academy of Engineering and the Academy of Medical Sciences, has joined a panel of internationally recognised experts for the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
As the worlds of science and technology come together, the 2015 Astellas Innovation Debate, organised and funded by Astellas, will discuss recent breakthroughs in genetic medicine and smart technology, and what they mean for our health.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7432051-lionel-tarassenko-astellas-debate/
The National Inventors Hall of Fame and the United States Patent and Trademark Office (USPTO) will host the Greatest Celebration of American Innovation May 4-5. The two-day event will include the Induction of 16 innovation trailblazers into the Hall of Fame and the unveiling of the expanded National Inventors Hall of Fame Museum.
Mo Rocca, Emmy award-winning CBS Sunday Morning correspondent and Host of The Henry Ford’s Innovation Nation, will give the first official museum tour and serve as Master of Ceremonies for the 44th Annual National Inventors Hall of Fame Induction Ceremony. Participants will have the opportunity to be historians and visionaries as both events focus on honoring the past and inspiring the future.
To view the multimedia release go to:
http://www.multivu.com/players/English/7667851-national-inventors-hall-of-fame/
Patients and scientists from across the country are featured in the latest “From Hope to Cures” ad campaign launched today by the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents the country’s leading biopharmaceutical researchers and biotechnology companies.
This continuation of PhRMA’s “From Hope to Cures” campaign, first launched in January 2014, highlights the value biopharmaceutical innovation provides to patients, society and the economy. The latest ad campaign, featuring print, radio and digital advertising, highlights the stories of patients who benefit from the medicines developed by biopharmaceutical companies and the scientists who work every day to develop life-saving treatments and cures.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7350552-phrma-from-hope-to-cures/
Chili’s® Grill & Bar, one of America’s leading casual dining restaurant brands, started with burgers on its original menu and today added new craft burgers tied to the launch of the brand’s new national heritage campaign, Chilin’ Since ’75™. Starting July 5, all restaurants nationwide will launch the new Sunrise Burger featuring a cage-free egg on top and the Ultimate Bacon Burger, both of which are now available with the option of a 100 percent grass-fed patty, which has no antibiotics or added hormones.
From transparent 3D televisions to bicycles you ride standing up, innovation was the name of the game at this year’s spring installment of the Canton Fair. Now, with the introduction of the new Canton Fair Design Awards (CF Awards), China’s most prestigious trade show is really driving cutting edge design to the next level. “Made in China” is about to become “Created in China
Schick Hydro announced today the next step in its quest to foster innovation by spotlighting and investing in a community that continues to transform the industry – independent game developers. The brand’s efforts include a new, fan-choice award for The Game Awards 2017 (“The Best Debut Indie Game – Presented by Schick Hydro”), a consumer giveaway that puts break-out indie games in fans’ hands, an exclusive indie game jam in partnership with Playcrafting and a custom arcade experience at The Game Awards.
“From the launch of the Schick Hydro 3 to the evolution of Schick Hydro 5, Schick Hydro is a challenger brand that’s constantly evolving to enhance the men’s grooming experience and bring innovation to the category,” said Anastasia Tobias, Senior Brand Manager of Schick Hydro at Edgewell Personal Care. “Innovation is about challenging the status quo to create something that enhances people’s lives. As innovators, it’s important that we support other innovators, which is why we’re extending our mission to “protect and defend” to indie game developers – creating opportunities for these rising-stars to continue to hone their craft and advance their industry.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8232951-schick-hydro-the-game-awards/
